RAD51D and breast cancer: By means of this approach, we successfully mapped SREs in the breast cancer (BC) susceptibility genes BRCA2 (MIM#600185), including exon 17 with a GC-5′ss, CHEK2 (MIM#604373), and RAD51D (MIM#602954) [3,7,8,9].